hVIVO plc (AIM: HVO)
Health Care · Life Sciences Tools & Services · GB
£0.06
-1.67% today · -23.1% 1Y
hVIVO plc (AIM: HVO) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $54.55M.
Over the last twelve months the share price has lost 23.1%, trading between 0.04 and 0.11.
Tweenvest scores hVIVO plc across four factors: quality 68/100, value 74/100, growth 78/100. Its strongest factor is growth.
HVO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $54.55M
- Revenue (TTM)
- $66.84M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.66
- 52-week high
- £0.11
- 52-week low
- £0.04
- Avg volume (3M)
- —
- Shares outstanding
- 687.01M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Immuno-Biological Laboratories Co., Ltd.TSE: 4570 | $63.05M | ¥1,072.00 | -6.38% |
| Fabtech Technologies LimitedNSEI: FABTECH | $61.19M | Rs133.22 | -6.19% |
| Pangaea Oncology, S.A.BME: PANG | $57.50M | €1.43 | 0.00% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $55.22M | $0.45 | -7.81% |
| Carna Biosciences, Inc.TSE: 4572 | $49.53M | ¥368.00 | -10.90% |
| ENCell Co., Ltd.KOSDAQ: A456070 | $48.16M | ₩5,870.00 | -2.17% |
| Chiome Bioscience Inc.TSE: 4583 | $46.85M | ¥94.00 | -7.84% |
| Austar Lifesciences LimitedSEHK: 6118 | $45.72M | HK$0.70 | -2.78% |
Figures last refreshed Oct 11, 2026.